163 related articles for article (PubMed ID: 23164394)
1. Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists.
Yang HY; Wang JD; Lo TC; Chen PC
J Urol; 2013 Jan; 189(1):48-52. PubMed ID: 23164394
[TBL] [Abstract][Full Text] [Related]
2. Editorial comment.
Landrigan PJ
J Urol; 2013 Jan; 189(1):52. PubMed ID: 23164374
[No Abstract] [Full Text] [Related]
3. Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids.
Yang HY; Wang JD; Lo TC; Chen PC
Occup Environ Med; 2011 Apr; 68(4):286-90. PubMed ID: 20935286
[TBL] [Abstract][Full Text] [Related]
4. Increased risks of upper tract urothelial carcinoma in male and female chinese herbalists.
Yang HY; Wang JD; Lo TC; Chen PC
J Formos Med Assoc; 2011 Mar; 110(3):161-8. PubMed ID: 21497279
[TBL] [Abstract][Full Text] [Related]
5. Association of blood lead and mercury with estimated GFR in herbalists after the ban of herbs containing aristolochic acids in Taiwan.
Lin HH; Chou SA; Yang HY; Hwang YH; Kuo CH; Kao TW; Lo TC; Chen PC
Occup Environ Med; 2013 Aug; 70(8):545-51. PubMed ID: 23703822
[TBL] [Abstract][Full Text] [Related]
6. Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.
Dickman KG; Chen CH; Grollman AP; Pu YS
World J Urol; 2023 Apr; 41(4):899-907. PubMed ID: 35867141
[TBL] [Abstract][Full Text] [Related]
7. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
[TBL] [Abstract][Full Text] [Related]
8. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
Nortier JL; Martinez MC; Schmeiser HH; Arlt VM; Bieler CA; Petein M; Depierreux MF; De Pauw L; Abramowicz D; Vereerstraeten P; Vanherweghem JL
N Engl J Med; 2000 Jun; 342(23):1686-92. PubMed ID: 10841870
[TBL] [Abstract][Full Text] [Related]
9. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
Lai MN; Wang SM; Chen PC; Chen YY; Wang JD
J Natl Cancer Inst; 2010 Feb; 102(3):179-86. PubMed ID: 20026811
[TBL] [Abstract][Full Text] [Related]
10. Chinese herbal uropathy and nephropathy.
Laing C; Hamour S; Sheaff M; Miller R; Woolfson R
Lancet; 2006 Jul; 368(9532):338. PubMed ID: 16860704
[No Abstract] [Full Text] [Related]
11. Urothelial malignant disease and Chinese herbal nephropathy.
Lord GM; Cook T; Arlt VM; Schmeiser HH; Williams G; Pusey CD
Lancet; 2001 Nov; 358(9292):1515-6. PubMed ID: 11705569
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.
Yang HY; Chen PC; Wang JD
Biomed Res Int; 2014; 2014():569325. PubMed ID: 25431765
[TBL] [Abstract][Full Text] [Related]
13. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
[TBL] [Abstract][Full Text] [Related]
14. [Induction of urothelial carcinoma due to chronic arsenic ingestion? A occupational medicine-toxicological excursion].
Müller M; Böcher A; Buchter A
Urologe A; 2007 May; 46(5):511-2, 514-5. PubMed ID: 17216513
[TBL] [Abstract][Full Text] [Related]
15. Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.
Chen CH; Grollman AP; Huang CY; Shun CT; Sidorenko VS; Hashimoto K; Moriya M; Turesky RJ; Yun BH; Tsai K; Wu S; Chuang PY; Tang CH; Yang WH; Tzai TS; Tsai YS; Dickman KG; Pu YS
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):317-325. PubMed ID: 33277322
[TBL] [Abstract][Full Text] [Related]
16. Re: Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
Su YC; Lin JS; Lee MT; Li TC; Lee SM
J Natl Cancer Inst; 2010 Jul; 102(13):988; author reply 988-90. PubMed ID: 20479292
[No Abstract] [Full Text] [Related]
17. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study.
Lai MN; Lai JN; Chen PC; Hsieh SC; Hu FC; Wang JD
Am J Kidney Dis; 2010 Mar; 55(3):507-18. PubMed ID: 20116155
[TBL] [Abstract][Full Text] [Related]
18. Aristolochic acid-associated urothelial cancer in Taiwan.
Chen CH; Dickman KG; Moriya M; Zavadil J; Sidorenko VS; Edwards KL; Gnatenko DV; Wu L; Turesky RJ; Wu XR; Pu YS; Grollman AP
Proc Natl Acad Sci U S A; 2012 May; 109(21):8241-6. PubMed ID: 22493262
[TBL] [Abstract][Full Text] [Related]
19. Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists.
Yang HY; Wang JD; Lo TC; Chen PC
J Epidemiol; 2009; 19(1):17-23. PubMed ID: 19164871
[TBL] [Abstract][Full Text] [Related]
20. [Renal interstitial fibrosis and urotelial carcinomas after ingestion of a Chinese herb (Aristolochia fangchi)].
Nortier J
Nephrologie; 2002; 23(1):37-8. PubMed ID: 11908479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
